CTOs on the Move

Bioness

www.bioness.com

 
Bioness offers award-winning medical devices designed to benefit people with stroke, Multiple Sclerosis, traumatic brain injury, Cerebral Palsy, and spinal cord injury. These products use electrical stimulation to help people regain mobility and
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.bioness.com
  • 25103 Rye Canyon Loop
    Valencia, CA USA 91355
  • Phone: 661.362.4850

Executives

Name Title Contact Details

Similar Companies

Canadian Hospital Specialties

Canadian Hospital Specialties Ltd is a Oakville, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

DHC USA

DHC USA is a San Francisco, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MicroCal

MicroCal, LLC is a Northampton, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Tandem Diabetes Care

Tandem Diabetes Care, Inc. (www.tandemdiabetes.com) is a medical device company with an innovative, user-centric and integrated approach to the design, development and commercialization of products for people with diabetes who use insulin. The Company manufactures and sells the t:slim® Insulin Pump, the slimmest and smallest durable insulin pump currently on the market; the t:flex® Insulin Pump, the first pump designed for people with greater insulin requirements; and the t:slim G4™ Insulin Pump, the first CGM-enabled pump with touch-screen simplicity. Tandem is based in San Diego, California.

Shockwave Medical

Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotrispy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. In peripheral vascular clinical study of moderate and severely calcified lesions in 95 patients, IVL demonstrated safety and consistent procedure success with low procedural complications. The technology is inherently familiar, easy to use, operates with just the push of a button, and works with existing cardiovascular treatments. And because it is built on a traditional balloon catheter platform, it integrates seamlessly with clinicians` existing workflow.